Johnson & Johnson (NYSE: JNJ) is expanding the U.S. roll-out of its latest advancement in presbyopia-correcting intraocular ...
FDA approval covers capsular-bag implantation for adult aphakia correction with <1.0 D corneal astigmatism; a toric PureSee Toric II option targets ≥1.0 D astigmatism. Pivotal US randomized, masked, ...
This valuable study uses naturalistic movie-viewing fMRI and stacked encoding models to investigate sensory feature representations in autistic and non-autistic youth, showing a relative shift toward ...
A recent study in the Indian Journal of Ophthalmology in January 2026 reveals that computer vision syndrome significantly ...